BH

BHTGY

Beijing Haizhi Technology Group Co., Ltd.

OTC· CIK 0002125951

—

Price

Daily candles with volume.

Recent activity

The latest filings, insider trades, analyst actions, press and options flow — newest first.

Oct 12, 2026 Clinical trial readout

Results Pending: Hydronidone capsules (Phase 2) — Completed 77d ago

Trial: A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibr

Catalysts

Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.

Recent

Results Pending: Hydronidone capsules (Phase 2) — Completed 77d ago

Trial: A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis Sponsor: Beijing Continent Pharmaceutical…

Results Pending: Hydronidone Capsules (Phase 3) — Completed 76d ago

Trial: A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis Sponsor: Beijing…

Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Drug Naive Type 2 Diabetes Patients

Phase 2 · COMPLETED

T-90d Trial Readout: CM355 (Phase 2)

Trial: A Phase I/II Study of CM355 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL) Sponsor: Beijing InnoCare Pharma…

YN001-004 in Patients With Coronary Atherosclerosis in Australia

Phase 2 · TERMINATED